ERYTECH Provides Business and Financial Highlights for First Quarter 2016 Post author:admERY Post published:May 10, 2016 Post category:Newsroom Erytech today provided a business update and reported financial results for its first quarter ended March 31, 2016. You Might Also Like ERYTECH Presents New Preclinical Data on ERY-MET at the 2017 ASCO GI Symposium January 17, 2017 ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016 ERYTECH’S COMBINED SHAREHOLDERS’ MEETING May 26, 2020
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
